EBV-Related Hodgkin Lymphoma — Trials

EBV-Related Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

5 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1
Recruiting: 1
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Baylor College of Medicine
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03546101	Early Detection of Epstein-Barr Virus Related Disease.	completed	—	1,527	University of AarhusOTHER	1	Oct 31, 2023	clinicaltrials
NCT02973113	Nivolumab With Epstein Barr Virus Specific T Cells (EBVSTS), Relapsed/Refractory EBV Positive Lymphoma (PREVALE)(PREVALE)	completed	Phase 1	8	Baylor College of MedicineOTHER	1	Jul 21, 2021	clinicaltrials